FEB 24, 2016 02:00 PM PST

Why we should clinically classify genotypes, not variants

C.E. CREDITS: P.A.C.E. CE
Speakers
  • Senior Director, Scientific Engagement & Public Outreach, New York Genome Center
    Biography
      Nathan Pearson is a Senior Director of Scientific Engagement & Public Outreach at NY Genome Center, where he and his colleagues build simple, engaging tools that compare one whole human genome to the next, in order to cast new light on human health and history. Fascinated by human genetic diversity since working as a young student in the laboratory of Luca Cavalli-Sforza (Stanford University), he traveled with Spencer Wells (now head of the Genographic Project) to collect DNA from people living throughout Eurasia, to reveal traces of ancient migrations recorded in their genomes. In doctoral work at the University of Chicago, he studied patterns of sequence variation on the great ape sex chromosomes, spotlighting how mutation, recombination, and natural selection have jointly made the X and Y ever more different from each other. Later, in post-doctoral work at the University of Michigan, he first delved into the emerging world of high-throughput sequencing, grasping its power to address important open questions in biology. Today, working with a talented team of scientists and programmers, he helps researchers and consumers sift through the billions of letters in each human genome, and understand which important spellings make each person unique.

    Abstract:

    A century and a half after we first probed heritability, we risk forgetting one of Mendel's own basic findings, in rushing to broaden clinical genomics to lifelong care for all. Embracing that key insight now -- as we long have in tracking the chemistry of health -- can help gird our health infrastructure for the long haul.

    Learning objectives

    • Conventionally, we clinically classify and report genomic variants.
    • That habit -- rooted in early clinical genomics (reading few genes, in few people, mostly sick) -- presumes that disease cases trace mainly to strongly acting single variants...so sweeps widespread real impenetrance, for major diseases, under a vast rug.
    • Classifying and reporting genotypes would more neatly and realistically track non-additive genomic interactions mined from emerging data, girding healthcare for broad longterm genomic utility.
    •  The history of toxicology (and of early genetics too!) starkly highlights this lesson, and suggests simple but urgent steps that stakeholders (genomicists, informaticians, caregivers, and patients) should take now.


     


    Show Resources
    You May Also Like
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...
    Show Resources